metastasis: be to rare

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents process
Weight: 0.57
, prostate cancer
Weight: 0.55
, characteristic
Weight: 0.53
, condition
Weight: 0.49
, cancer cell
Weight: 0.49
Siblings breast cancer
Weight: 0.34
, apoptosis
Weight: 0.34
, phagocytosis
Weight: 0.33
, cystic fibrosis
Weight: 0.33
, heart disease
Weight: 0.33

Related properties

Property Similarity
be to rare 1.00
be rare in countries 0.88
be rare in developing countries 0.80
be to spleen rare 0.76

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.08
Rule weight: 0.13
Evidence weight: 0.68
Similarity weight: 0.88
Evidence: 0.51
¬ Remarkable(metastasis, be to rare) ⋁
Evidence: 0.62
¬ Remarkable(breast cancer, be rare in countries)
0.08
Rule weight: 0.13
Evidence weight: 0.75
Similarity weight: 0.80
Evidence: 0.51
¬ Remarkable(metastasis, be to rare) ⋁
Evidence: 0.50
¬ Remarkable(breast cancer, be rare in developing countries)

Remarkability from sibling implausibility

0.47
Rule weight: 0.60
Evidence weight: 0.90
Similarity weight: 0.88
Evidence: 0.51
Plausible(metastasis, be to rare) ⋁
Evidence: 0.62
Remarkable(breast cancer, be rare in countries) ⋁
Evidence: 0.55
¬ Plausible(breast cancer, be rare in countries)
0.40
Rule weight: 0.60
Evidence weight: 0.83
Similarity weight: 0.80
Evidence: 0.51
Plausible(metastasis, be to rare) ⋁
Evidence: 0.50
Remarkable(breast cancer, be rare in developing countries) ⋁
Evidence: 0.69
¬ Plausible(breast cancer, be rare in developing countries)

Salient implies Plausible

0.21
Rule weight: 0.28
Evidence weight: 0.75
Similarity weight: 1.00
Evidence: 0.51
Plausible(metastasis, be to rare) ⋁
Evidence: 0.52
¬ Salient(metastasis, be to rare)

Similarity expansion

0.49
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.76
Evidence: 0.56
Typical(metastasis, be to rare) ⋁
Evidence: 0.54
¬ Typical(metastasis, be to spleen rare)
0.46
Rule weight: 0.85
Evidence weight: 0.72
Similarity weight: 0.76
Evidence: 0.51
Plausible(metastasis, be to rare) ⋁
Evidence: 0.58
¬ Plausible(metastasis, be to spleen rare)
0.42
Rule weight: 0.85
Evidence weight: 0.65
Similarity weight: 0.76
Evidence: 0.52
Salient(metastasis, be to rare) ⋁
Evidence: 0.72
¬ Salient(metastasis, be to spleen rare)
0.41
Rule weight: 0.85
Evidence weight: 0.63
Similarity weight: 0.76
Evidence: 0.51
Remarkable(metastasis, be to rare) ⋁
Evidence: 0.76
¬ Remarkable(metastasis, be to spleen rare)

Typical and Remarkable implies Salient

0.12
Rule weight: 0.14
Evidence weight: 0.86
Similarity weight: 1.00
Evidence: 0.52
Salient(metastasis, be to rare) ⋁
Evidence: 0.56
¬ Typical(metastasis, be to rare) ⋁
Evidence: 0.51
¬ Remarkable(metastasis, be to rare)

Typical implies Plausible

0.35
Rule weight: 0.48
Evidence weight: 0.73
Similarity weight: 1.00
Evidence: 0.51
Plausible(metastasis, be to rare) ⋁
Evidence: 0.56
¬ Typical(metastasis, be to rare)

Typicality and Rermarkability incompatibility between siblings

0.08
Rule weight: 0.14
Evidence weight: 0.70
Similarity weight: 0.88
Evidence: 0.51
¬ Remarkable(metastasis, be to rare) ⋁
Evidence: 0.59
¬ Typical(breast cancer, be rare in countries)
0.07
Rule weight: 0.14
Evidence weight: 0.60
Similarity weight: 0.80
Evidence: 0.51
¬ Remarkable(metastasis, be to rare) ⋁
Evidence: 0.78
¬ Typical(breast cancer, be rare in developing countries)